Funding · 24 February 2026Oncare₹27 CrDistributed oncology care network
FundingHealthcare & Life Sciences
Oncare raises ₹27 crore in Series A round
By Abha Lohia · Editor ·
Series AFounded 2023
- Oncare runs a distributed oncology care model partnering with accredited hospitals
- It raised ₹27 crore in Series A led by Sky Impact Capital with Huddle Ventures and others
- The funds will expand into metro and Tier-2/3 cities and improve technology for patient care
What happened
- Oncare raised ₹27 crore in a Series A funding round.
- The round was led by Sky Impact Capital.
- Participating investors included Huddle Ventures, Lotus Herbal Group, SteerX, and Tremis Capital.
- The company will use the funds to expand into metro markets and Tier-2/Tier-3 cities.
- It will also invest in technology to improve clinical operations, care coordination, and patient experience.
- Oncare operates a distributed oncology care model that partners with accredited hospitals.
- The model integrates medical, surgical, and radiation oncology services.
Why it matters
- India's oncology care market is projected to reach ₹43,000 crore by FY28, growing at a CAGR of about 14%.
- Access to cancer treatment is uneven, with capacity concentrated in large hospitals.
- Indian healthtech startups raised nearly $700 million in 2025.
- Other funded oncology startups include 4baseCare, Everhope Oncology, and MOC Cancer Care.
The business
- Oncare was founded in 2023 by Amar Sneh and Deepak Kumar.
- It operates four centres across Delhi NCR.
- The company uses a capex-light model to build a national oncology network.
- It focuses on affordable, standardised, and transparent cancer care.
- Oncare integrates with insurance to make treatment accessible.
- It partners with accredited hospitals to deliver care.
The founders
AS
Amar Sneh
Co-founderDK
Deepak Kumar
Co-founder- Co-founder of Oncare.
- Stated that the company aims to make high-quality treatment accessible, transparent, and patient-focused.
Who put in money
- Sky Impact Capital lead — Investment firm focused on impact.
- Huddle Ventures participated — Venture capital firm.
- Lotus Herbal Group participated
- SteerX participated
- Tremis Capital participated
In numbers
₹27 croreSeries A amount · 2026
4Centres · 2026
$1 millionSeed round amount
What happens next
- Expand into metro markets and Tier-2/Tier-3 cities.
- Invest in technology to improve clinical operations, care coordination, and patient experience.
Earlier rounds
- Seed · $1 million · led by Huddle Ventures
Up against
4baseCareEverhope OncologyMOC Cancer CareErlySignOneCell Diagnostics
Words to know
- Series A
- The first significant round of venture capital funding, typically used to scale operations.
- Distributed oncology care model
- A network of smaller, partnered centres providing cancer treatment instead of a single large hospital.
- Capex-light model
- A business model that requires low capital expenditure on physical assets, relying on partnerships instead.
- CAGR
- Compound annual growth rate, the average annual growth rate over a specified period.
The numbers around it
Healthcare & Life Sciences in February 2026: 18 rounds with a disclosed amount, $66.5 million in all; the biggest was Pandorum Technologies ($18M). Every sector this year →
Other articles talking about it
Business Line ↗Inc42 ↗Entrackr ↗Indian Startup News ↗Indian Startup Times ↗Entrackr ↗Entrackr ↗indian-startup-times ↗
Terms in this story
- Tier-2 startups: A growing share of Indian startups now come from tier-2 and tier-3 cities and towns, helped by cheap data, lower costs and local problems that big-city founders do not see. Raising money and hiring senior talent remain the main hurdles.
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Series A: Series A is usually the first large round a startup raises from venture capital funds, after it has shown that people want what it sells. In India it commonly runs from a few million dollars to about $15 million, or roughly ₹25 crore to over ₹100 crore, with founders selling about 15 to 25 percent, as of November 2026.
- Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
All startup news on 24 February 2026 →
Is this Oncare? Get your “Featured on StopDown” badge →